Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 November 1995:
Vol. 270. no. 5237, pp. 819 - 822
DOI: 10.1126/science.270.5237.819
Prev | Table of Contents

Reports

Mutations in the Dystrophin-Associated Protein -Sarcoglycan in Chromosome 13 Muscular Dystrophy

Satoru Noguchi (1),  Elizabeth M. McNally,  Kamel Ben Othmane,  Yasuko Hagiwara,  Yuji Mizuno,  Mikiharu Yoshida,  Hideko Yamamoto,  Carsten G. Bönnemann,  Emanuela Gussoni,  Peter H. Denton,  Theodoros Kyriakides,  Lefkos Middleton,  Faycal Hentati,  Mongi Ben Hamida,  Ikuya Nonaka,  Jeffery M. Vance,  Louis M. Kunkel,  Eijiro Ozawa

Severe childhood autosomal recessive muscular dystrophy (SCARMD) is a progressive muscle-wasting disorder common in North Africa that segregates with microsatellite markers at chromosome 13q12. Here, it is shown that a mutation in the gene encoding the 35-kilodalton dystrophin-associated glycoprotein, -sarcoglycan, is likely to be the primary genetic defect in this disorder. The human -sarcoglycan gene was mapped to chromosome 13q12, and deletions that alter its reading frame were identified in three families and one of four sporadic cases of SCARMD. These mutations not only affect -sarcoglycan but also disrupt the integrity of the entire sarcoglycan complex.


S. Noguchi, Y. Hagiwara, Y. Mizuno, M. Yoshida, H. Yamamoto, I. Nonaka, E. Ozawa, National Institute of Neuroscience, National Center for Neurology and Psychiatry, 4-1-1 Ogawa-higashi cho, Kodaira, Tokyo, 187 Japan.
E. M. McNally, C. G. Bönnemann, E. Gussoni, L. M. Kunkel, Division of Genetics and the Howard Hughes Medical Institute, Children's Hospital, Boston, MA 02155, USA.
K. Ben Othmane, P. H. Denton, J. M. Vance, Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
T. Kyriakides and L. Middleton, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
F. Hentati and M. Ben Hamida, Institute of Neurology, Tunis, Tunisia.
(1) To whom correspondence should be addressed.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Overexpression of Galgt2 Reduces Dystrophic Pathology in the Skeletal Muscles of Alpha Sarcoglycan-Deficient Mice.
R. Xu, S. DeVries, M. Camboni, and P. T. Martin (2009)
Am. J. Pathol. 175, 235-247
   Abstract »    Full Text »    PDF »
Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin.
J. R. Guyon, J. Goswami, S. J. Jun, M. Thorne, M. Howell, T. Pusack, G. Kawahara, L. S. Steffen, M. Galdzicki, and L. M. Kunkel (2009)
Hum. Mol. Genet. 18, 202-211
   Abstract »    Full Text »    PDF »
Designing Heart Performance by Gene Transfer.
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger (2008)
Physiol Rev 88, 1567-1651
   Abstract »    Full Text »    PDF »
Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.
L. R. Rodino-Klapac, J-S Lee, R. C. Mulligan, K. R. Clark, and J. R. Mendell (2008)
Neurology 71, 240-247
   Abstract »    Full Text »    PDF »
Inhibition of Proteasome Activity Promotes the Correct Localization of Disease-Causing {alpha}-Sarcoglycan Mutants in HEK-293 Cells Constitutively Expressing {beta}-, {gamma}-, and {delta}-Sarcoglycan.
S. Gastaldello, S. D'Angelo, S. Franzoso, M. Fanin, C. Angelini, R. Betto, and D. Sandona (2008)
Am. J. Pathol. 173, 170-181
   Abstract »    Full Text »    PDF »
Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants.
M. J. Allikian, G. Bhabha, P. Dospoy, A. Heydemann, P. Ryder, J. U. Earley, M. J. Wolf, H. A. Rockman, and E. M. McNally (2007)
Hum. Mol. Genet. 16, 2933-2943
   Abstract »    Full Text »    PDF »
Sarcoglycan Subcomplex Expression in Normal Human Smooth Muscle.
G. Anastasi, G. Cutroneo, A. Sidoti, C. Rinaldi, D. Bruschetta, G. Rizzo, R. D'Angelo, G. Tarone, A. Amato, and A. Favaloro (2007)
J. Histochem. Cytochem. 55, 831-843
   Abstract »    Full Text »    PDF »
{alpha}7{beta}1 Integrin Does Not Alleviate Disease in a Mouse Model of Limb Girdle Muscular Dystrophy Type 2F.
D. J. Milner and S. J. Kaufman (2007)
Am. J. Pathol. 170, 609-619
   Abstract »    Full Text »    PDF »
Simultaneous Dystrophin and Dysferlin Deficiencies Associated with High-Level Expression of the Coxsackie and Adenovirus Receptor in Transgenic Mice.
C. A. Shaw, N. Larochelle, R. W.R. Dudley, H. Lochmuller, G. Danialou, B. J. Petrof, G. Karpati, P. C. Holland, and J. Nalbantoglu (2006)
Am. J. Pathol. 169, 2148-2160
   Abstract »    Full Text »    PDF »
A novel mutation in two families with limb-girdle muscular dystrophy type 2C..
D. R. Duncan, P. B. Kang, J. C. Rabbat, C. E. Briggs, H.G.W. Lidov, B. T. Darras, and L. M. Kunkel (2006)
Neurology 67, 167-169
   Abstract »    Full Text »    PDF »
Deficiency of {alpha}-sarcoglycan differently affects fast- and slow-twitch skeletal muscles.
D. Danieli-Betto, A. Esposito, E. Germinario, D. Sandona, T. Martinello, A. Jakubiec-Puka, D. Biral, and R. Betto (2005)
Am J Physiol Regulatory Integrative Comp Physiol 289, R1328-R1337
   Abstract »    Full Text »    PDF »
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.
G Piluso, L Politano, S Aurino, M Fanin, E Ricci, V M Ventriglia, A Belsito, A Totaro, V Saccone, H Topaloglu, et al. (2005)
J. Med. Genet. 42, 686-693
   Abstract »    Full Text »    PDF »
{gamma}-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesion.
M. A. Griffin, H. Feng, M. Tewari, P. Acosta, M. Kawana, H. L. Sweeney, and D. E. Discher (2005)
J. Cell Sci. 118, 1405-1416
   Abstract »    Full Text »    PDF »
{varepsilon}-Sarcoglycan compensates for lack of {alpha}-sarcoglycan in a mouse model of limb-girdle muscular dystrophy.
M. Imamura, Y. Mochizuki, E. Engvall, and S. Takeda (2005)
Hum. Mol. Genet. 14, 775-783
   Abstract »    Full Text »    PDF »
Assignment of a new congenital fibrosis of extraocular muscles type 3 (CFEOM3) locus, FEOM4, based on a balanced translocation t(2;13) (q37.3;q12.11) and identification of candidate genes.
P Aubourg, M Krahn, R Bernard, K Nguyen, O Forzano, I Boccaccio, V Delague, A De Sandre-Giovannoli, J Pouget, D Depetris, et al. (2005)
J. Med. Genet. 42, 253-259
   Full Text »    PDF »
Filamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibres.
J. Beatham, R. Romero, S. K.M. Townsend, T. Hacker, P. F.M. van der Ven, and G. Blanco (2004)
Hum. Mol. Genet. 13, 2863-2874
   Abstract »    Full Text »    PDF »
The Congenital and Limb-Girdle Muscular Dystrophies: Sharpening the Focus, Blurring the Boundaries.
J. Kirschner and C. G. Bonnemann (2004)
Arch Neurol 61, 189-199
   Abstract »    Full Text »    PDF »
{beta}-Catenin accumulates in intercalated disks of hypertrophic cardiomyopathic hearts.
L. Masuelli, R. Bei, P. Sacchetti, I. Scappaticci, P. Francalanci, L. Albonici, A. Coletti, C. Palumbo, M. Minieri, R. Fiaccavento, et al. (2003)
Cardiovasc Res 60, 376-387
   Abstract »    Full Text »    PDF »
Novel sarcoglycan gene mutations in a large cohort of Italian patients.
C Boito, M Fanin, G Siciliano, C Angelini, and E Pegoraro (2003)
J. Med. Genet. 40, e67-67
   Full Text »    PDF »
Genotype-phenotype correlations in 35 Brazilian families with sarcoglycanopathies including the description of three novel mutations.
E S Moreira, M Vainzof, O T Suzuki, R C M Pavanello, M Zatz, and M R Passos-Bueno (2003)
J. Med. Genet. 40, e12-12
   Full Text »    PDF »
Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
R. H. CROSBIE, R. BARRESI, and K. P. CAMPBELL (2002)
FASEB J 16, 1786-1791
   Abstract »    Full Text »    PDF »
{zeta}-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy.
M. T. Wheeler, S. Zarnegar, and E. M. McNally (2002)
Hum. Mol. Genet. 11, 2147-2154
   Abstract »    Full Text »    PDF »
Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy.
P. S. Chockalingam, R. Cholera, S. A. Oak, Y. Zheng, H. W. Jarrett, and D. B. Thomason (2002)
Am J Physiol Cell Physiol 283, C500-C511
   Abstract »    Full Text »    PDF »
Integrin {alpha}7{beta}1 in Muscular Dystrophy/Myopathy of Unknown Etiology.
E. Pegoraro, F. Cepollaro, P. Prandini, A. Marin, M. Fanin, C. P. Trevisan, A. H. El-Messlemani, G. Tarone, E. Engvall, E. P. Hoffman, et al. (2002)
Am. J. Pathol. 160, 2135-2143
   Abstract »    Full Text »    PDF »
Calsarcin-3, a Novel Skeletal Muscle-specific Member of the Calsarcin Family, Interacts with Multiple Z-disc Proteins.
N. Frey and E. N. Olson (2002)
J. Biol. Chem. 277, 13998-14004
   Abstract »    Full Text »    PDF »
The Sarcoglycan Complex in Striated and Vascular Smooth Muscle.
M.T. WHEELER, M.J. ALLIKIAN, A. HEYDEMANN, and E.M. MCNALLY (2002)
Cold Spring Harb Symp Quant Biol 67, 389-398
   Abstract »    PDF »
{gamma}-Sarcoglycanopathy in Two Palestinian-American Siblings.
S. R. Russo Buzzini and C. Macmillan (2001)
Clinical Pediatrics 40, 115-117
   PDF »
Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated I{kappa}b{alpha}/Nuclear Factor {kappa}b Pathway Perturbation in Mice.
I. Richard, C. Roudaut, S. Marchand, S. Baghdiguian, M. Herasse, D. Stockholm, Y. Ono, L. Suel, N. Bourg, H. Sorimachi, et al. (2000)
J. Cell Biol. 151, 1583-1590
   Abstract »    Full Text »    PDF »
Expression Profiling in the Muscular Dystrophies: Identification of Novel Aspects of Molecular Pathophysiology.
Y.-W. Chen, P. Zhao, R. Borup, and E. P. Hoffman (2000)
J. Cell Biol. 151, 1321-1336
   Abstract »    Full Text »    PDF »
A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system.
M. Imamura, K. Araishi, S. Noguchi, and E. Ozawa (2000)
Hum. Mol. Genet. 9, 3091-3100
   Abstract »    Full Text »    PDF »
Indications for a Novel Muscular Dystrophy Pathway: {gamma}-Filamin, the Muscle-Specific Filamin Isoform, Interacts with Myotilin.
P. F.M. van der Ven, S. Wiesner, P. Salmikangas, D. Auerbach, M. Himmel, S. Kempa, K. Hayess, D. Pacholsky, A. Taivainen, R. Schroder, et al. (2000)
J. Cell Biol. 151, 235-248
   Abstract »    Full Text »    PDF »
Animal models for muscular dystrophy: valuable tools for the development of therapies.
V. Allamand and K. P. Campbell (2000)
Hum. Mol. Genet. 9, 2459-2467
   Abstract »    Full Text »    PDF »
Assembly of the Dystrophin-Associated Protein Complex Does Not Require the Dystrophin Cooh-Terminal Domain.
G. E. Crawford, J. A. Faulkner, R. H. Crosbie, K. P. Campbell, S. C. Froehner, and J. S. Chamberlain (2000)
J. Cell Biol. 150, 1399-1410
   Abstract »    Full Text »    PDF »
Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions.
R. H. Crosbie, L. E. Lim, S. A. Moore, M. Hirano, A. P. Hays, S. W. Maybaum, H. Collin, S. A. Dovico, C. A. Stolle, M. Fardeau, et al. (2000)
Hum. Mol. Genet. 9, 2019-2027
   Abstract »    Full Text »    PDF »
Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease.
M. W. Berchtold, H. Brinkmeier, and M. Muntener (2000)
Physiol Rev 80, 1215-1265
   Abstract »    Full Text »    PDF »
A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families.
P. Dinçer, Z. Akçören, E. Demir, I. Richard, O. Sancak, G. Kale, E. Tan, J A. Urtizberea, and J. S Beckmann (2000)
J. Med. Genet. 37, 361-367
   Abstract »    Full Text »
Homogeneous phenotype of the gypsy limb-girdle MD with the {gamma}-sarcoglycan C283Y mutation.
L. Merlini, J-C. Kaplan, C. Navarro, A. Barois, D. Bonneau, J. Brasa, B. Echenne, P. Gallano, L. Jarre, M. Jeanpierre, et al. (2000)
Neurology 54, 1075-1079
   Abstract »    Full Text »    PDF »
Sarcospan-Deficient Mice Maintain Normal Muscle Function.
C. S. Lebakken, D. P. Venzke, R. F. Hrstka, C. M. Consolino, J. A. Faulkner, R. A. Williamson, and K. P. Campbell (2000)
Mol. Cell. Biol. 20, 1669-1677
   Abstract »    Full Text »
Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations.
R. Barresi, C. Di Blasi, T. Negri, R. Brugnoni, A. Vitali, G. Felisari, A. Salandi, S. Daniel, F. Cornelio, L. Morandi, et al. (2000)
J. Med. Genet. 37, 102-107
   Abstract »    Full Text »
Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.
A. Hack, M. Lam, L Cordier, D. Shoturma, C. Ly, M. Hadhazy, M. Hadhazy, H. Sweeney, and E. McNally (2000)
J. Cell Sci. 113, 2535-2544
   Abstract »    PDF »
Sarcoglycan Isoforms in Skeletal Muscle.
L. A. Liu and E. Engvall (1999)
J. Biol. Chem. 274, 38171-38176
   Abstract »    Full Text »    PDF »
Muscle degeneration without mechanical injury in sarcoglycan deficiency.
A. A. Hack, L. Cordier, D. I. Shoturma, M. Y. Lam, H. L. Sweeney, and E. M. McNally (1999)
PNAS 96, 10723-10728
   Abstract »    Full Text »    PDF »
The limb-girdle muscular dystrophies--multiple genes,multiple mechanisms.
K. M. D. Bushby (1999)
Hum. Mol. Genet. 8, 1875-1882
   Abstract »    Full Text »    PDF »
Limb-girdle muscular dystrophy with apparently different clinical courses within sexes in a large inbred kindred.
G. F LEAL and E. O DA-SILVA (1999)
J. Med. Genet. 36, 714-718
   Full Text »
Making sense of the limb-girdle muscular dystrophies.
K. M. D. Bushby (1999)
Brain 122, 1403-1420
   Abstract »    Full Text »    PDF »
{alpha}-Dystroglycan Is a Laminin Receptor Involved in Extracellular Matrix Assembly on Myotubes and Muscle Cell Viability.
F. Montanaro, M. Lindenbaum, and S. Carbonetto (1999)
J. Cell Biol. 145, 1325-1340
   Abstract »    Full Text »    PDF »
Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex.
R. H. Crosbie, C. S. Lebakken, K. H. Holt, D. P. Venzke, V. Straub, J. C. Lee, R. M. Grady, J. S. Chamberlain, J. R. Sanes, and K. P. Campbell (1999)
J. Cell Biol. 145, 153-165
   Abstract »    Full Text »    PDF »
Ecto-ATPase Activity of alpha -Sarcoglycan (Adhalin).
R. Betto, L. Senter, S. Ceoldo, E. Tarricone, D. Biral, and G. Salviati (1999)
J. Biol. Chem. 274, 7907-7912
   Abstract »    Full Text »    PDF »
Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population.
F.-L. Chou, C. Angelini, D. Daentl, C. Garcia, C. Greco, I. Hausmanowa-Petrusewicz, A. Fidzianska, H. Wessel, and E. P. Hoffman (1999)
Neurology 52, 1015
   Abstract »    Full Text »
Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in Culture.
Y.-m. Chan, C. G. Bonnemann, H. G.W. Lidov, and L. M. Kunkel (1998)
J. Cell Biol. 143, 2033-2044
   Abstract »    Full Text »    PDF »
Assembly of the Sarcoglycan Complex. INSIGHTS FOR MUSCULAR DYSTROPHY.
K. H. Holt and K. P. Campbell (1998)
J. Biol. Chem. 273, 34667-34670
   Abstract »    Full Text »    PDF »
Molecular Pathogenesis of Muscle Degeneration in the {delta}-Sarcoglycan-Deficient Hamster.
V. Straub, F. Duclos, D. P. Venzke, J. C. Lee, S. Cutshall, C. J. Leveille, and K. P. Campbell (1998)
Am. J. Pathol. 153, 1623-1630
   Abstract »    Full Text »    PDF »
Characterization of Monoclonal Antibodies to Calpain 3 and Protein Expression in Muscle from Patients with Limb-Girdle Muscular Dystrophy Type 2A.
L. V. B. Anderson, K. Davison, J. A. Moss, I. Richard, M. Fardeau, F. M. S. Tome, C. Hubner, A. Lasa, J. Colomer, and J. S. Beckmann (1998)
Am. J. Pathol. 153, 1169-1179
   Abstract »    Full Text »    PDF »
Progressive Muscular Dystrophy in {alpha}-Sarcoglycan-deficient Mice.
F. Duclos, V. Straub, S. A. Moore, D. P. Venzke, R. F. Hrstka, R. H. Crosbie, M. Durbeej, C. S. Lebakken, A. J. Ettinger, J. van der Meulen, et al. (1998)
J. Cell Biol. 142, 1461-1471
   Abstract »    Full Text »    PDF »
{gamma}-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin.
A. A. Hack, C. T. Ly, F. Jiang, C. J. Clendenin, K. S. Sigrist, R. L. Wollmann, and E. M. McNally (1998)
J. Cell Biol. 142, 1279-1287
   Abstract »    Full Text »    PDF »
Functional Defects of a Muscle-specific Calpain, p94, Caused by Mutations Associated with Limb-Girdle Muscular Dystrophy Type 2A.
Y. Ono, H. Shimada, H. Sorimachi, I. Richard, T. C. Saido, J. S. Beckmann, S. Ishiura, and K. Suzuki (1998)
J. Biol. Chem. 273, 17073-17078
   Abstract »    Full Text »    PDF »
Bidirectional Signaling between Sarcoglycans and the Integrin Adhesion System in Cultured L6 Myocytes.
T. Yoshida, Y. Pan, H. Hanada, Y. Iwata, and M. Shigekawa (1998)
J. Biol. Chem. 273, 1583-1590
   Abstract »    Full Text »    PDF »
The heart in limb girdle muscular dystrophy.
A J van der Kooi, W G de Voogt, P G Barth, H F M Busch, F G I Jennekens, P J H Jongen, and M de Visser (1998)
Heart 79, 73-77
   Abstract »    Full Text »    PDF »
epsilon -Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D.
A. J. Ettinger, G. Feng, and J. R. Sanes (1997)
J. Biol. Chem. 272, 32534-32538
   Abstract »    Full Text »    PDF »
Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta -sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex.
A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka, and F. Hanaoka (1997)
PNAS 94, 13873-13878
   Abstract »    Full Text »    PDF »
Dystrophin-Glycoprotein Complex Is Monomeric and Stabilizes Actin Filaments in Vitro through a Lateral Association.
I. N. Rybakova and J. M. Ervasti (1997)
J. Biol. Chem. 272, 28771-28778
   Abstract »    Full Text »    PDF »
Mutations in the Sarcoglycan Genes in Patients with Myopathy.
D. J. Duggan, J. R. Gorospe, M. Fanin, E. P. Hoffman, C. Angelini, E. Pegoraro, S. Noguchi, E. Ozawa, W. Pendlebury, A.J. Waclawik, et al. (1997)
N. Engl. J. Med. 336, 618-625
   Abstract »    Full Text »    PDF »
Characterization of delta -Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy.
D. Jung, F. Duclos, B. Apostol, V. Straub, J. C. Lee, V. Allamand, D. P. Venzke, Y. Sunada, C. R. Moomaw, C. J. Leveille, et al. (1996)
J. Biol. Chem. 271, 32321-32329
   Abstract »    Full Text »    PDF »
Structure of the Human Laminin alpha 2-Chain Gene (LAMA2), Which Is Affected in Congenital Muscular Dystrophy.
X. Zhang, R. Vuolteenaho, and K. Tryggvason (1996)
J. Biol. Chem. 271, 27664-27669
   Abstract »    Full Text »    PDF »
Deficiency of Adhalin in a Patient with Muscular Dystrophy and Cardiomyopathy.
E. McNally, C. Bonnemann, L. Kunkel, S. K. Bhattacharya, B.P. Lotz, and A.J. Waclawik (1996)
N. Engl. J. Med. 334, 1610-1611
   Full Text »
Recent Advances: Medical genetics.
J. R W Yates (1996)
BMJ 312, 1021-1025
   Abstract »    Full Text »
ENHANCED PERSPECTIVE: Muscular Dystrophies--Diseases of the Dystrophin-Glycoprotein Complex.
R. Worton (1995)
Science 270, 755
   Abstract »    Full Text »    PDF »
gamma 1- and gamma 2-Syntrophins, Two Novel Dystrophin-binding Proteins Localized in Neuronal Cells.
G. Piluso, M. Mirabella, E. Ricci, A. Belsito, C. Abbondanza, S. Servidei, A. A. Puca, P. Tonali, G. A. Puca, and V. Nigro (2000)
J. Biol. Chem. 275, 15851-15860
   Abstract »    Full Text »    PDF »
Expression of gamma -Sarcoglycan in Smooth Muscle and Its Interaction with the Smooth Muscle Sarcoglycan-Sarcospan Complex.
R. Barresi, S. A. Moore, C. A. Stolle, J. R. Mendell, and K. P. Campbell (2000)
J. Biol. Chem. 275, 38554-38560
   Abstract »    Full Text »    PDF »
Overexpression of gamma -Sarcoglycan Induces Severe Muscular Dystrophy. IMPLICATIONS FOR THE REGULATION OF SARCOGLYCAN ASSEMBLY.
X. Zhu, M. Hadhazy, M. E. Groh, M. T. Wheeler, R. Wollmann, and E. M. McNally (2001)
J. Biol. Chem. 276, 21785-21790
   Abstract »    Full Text »    PDF »
Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin.
Y. Mizuno, T. G. Thompson, J. R. Guyon, H. G. W. Lidov, M. Brosius, M. Imamura, E. Ozawa, S. C. Watkins, and L. M. Kunkel (2001)
PNAS 98, 6156-6161
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)